{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T13:10:02Z","timestamp":1789650602059,"version":"4.0.0"},"reference-count":227,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.jaut.2018.10.004","type":"journal-article","created":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T09:31:09Z","timestamp":1540287069000},"page":"144-158","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"special_numbering":"C","title":["The clinical usage and definition of autoantibodies in immune-mediated liver disease: A comprehensive overview"],"prefix":"10.1016","volume":"95","author":[{"given":"Benedetta","family":"Terziroli Beretta-Piccoli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgina","family":"Mieli-Vergani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Vergani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2018.10.004_bib1","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/hep.22322","article-title":"Simplified criteria for the diagnosis of autoimmune hepatitis","volume":"48","author":"Hennes","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2018.10.004_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2016.07.005","article-title":"Cutting edge issues in autoimmune hepatitis","author":"Liberal","year":"2016","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2018.10.004_bib3","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/hep4.1044","article-title":"Toward solving the etiological mystery of primary biliary cholangitis","volume":"1","author":"Tanaka","year":"2017","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.jaut.2018.10.004_bib4","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jhep.2017.03.022","article-title":"Electronic address: easloffice@easloffice.eu, European Association for the Study of the Liver. EASL Clinical Practice Guidelines: the diagnosis and management of patients with primary biliary cholangitis","volume":"67","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jaut.2018.10.004_bib5","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/liv.13238","article-title":"Antineutrophil antibodies define clinical and genetic subgroups in primary sclerosing cholangitis","volume":"37","author":"Hov","year":"2017","journal-title":"Liver Int."},{"key":"10.1016\/j.jaut.2018.10.004_bib6","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1053\/jhep.2001.22131","article-title":"Autoimmune hepatitis\/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study","volume":"33","author":"Gregorio","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2018.10.004_bib7","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.jhep.2004.08.002","article-title":"Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group","volume":"41","author":"Vergani","year":"2004","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jaut.2018.10.004_bib8","doi-asserted-by":"crossref","first-page":"609","DOI":"10.3389\/fimmu.2018.00609","article-title":"Autoantibodies in autoimmune liver disease-clinical and diagnostic relevance","volume":"9","author":"Sebode","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2018.10.004_bib9","article-title":"International Autoimmune Hepatitis Group (IAIHG). Autoimmune hepatitis: from current knowledge and clinical practice to future research agenda","author":"Sebode","year":"2017","journal-title":"Liver Int."},{"key":"10.1016\/j.jaut.2018.10.004_bib10","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jaut.2013.08.001","article-title":"Clinical significance of autoantibodies in autoimmune hepatitis","volume":"46","author":"Liberal","year":"2013","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2018.10.004_bib11","series-title":"The Autoimmune Diseases","first-page":"1161","article-title":"Chapter 77 - autoantibody assays: performance, interpretation, and standardization","author":"Fritzler","year":"2014"},{"key":"10.1016\/j.jaut.2018.10.004_bib12","doi-asserted-by":"crossref","first-page":"S100","DOI":"10.1016\/j.jhep.2015.03.005","article-title":"Autoimmune hepatitis\u2013Update 2015","volume":"62","author":"Manns","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jaut.2018.10.004_bib13","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.jhep.2015.06.030","article-title":"EASL clinical practice guidelines: autoimmune hepatitis","volume":"63","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jaut.2018.10.004_bib14","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/MPG.0b013e3181a1c265","article-title":"Autoimmune hepatitis","volume":"49","author":"Mieli-Vergani","year":"2009","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.jaut.2018.10.004_bib15","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1055\/s-0029-1233533","article-title":"Autoantibodies and their antigens in autoimmune hepatitis","volume":"29","author":"Bogdanos","year":"2009","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.jaut.2018.10.004_bib16","first-page":"1022","article-title":"The specificity of L.E. phenomenon","volume":"45","author":"Leoni","year":"1954","journal-title":"Minerva Med."},{"key":"10.1016\/j.jaut.2018.10.004_bib17","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0025-6196(25)10643-5","article-title":"Presentation of two bone marrow elements; the tart cell and the L.E. cell","volume":"23","author":"Hargraves","year":"1948","journal-title":"Proc. Staff Meet. Mayo Clin."},{"key":"10.1016\/j.jaut.2018.10.004_bib18","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/jid.1949.12","article-title":"Cells in the blood in acute disseminated lupus erythematosus","volume":"12","author":"Sundberg","year":"1949","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jaut.2018.10.004_bib19","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/S0140-6736(56)91483-0","article-title":"Lupoid hepatitis","volume":"268","author":"Mackay","year":"1956","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2018.10.004_bib20","series-title":"Chapter 61 - Hepatitis. The Autoimmune Diseases","first-page":"889","author":"Vergani","year":"2014"},{"key":"10.1016\/j.jaut.2018.10.004_bib21","article-title":"Serology in autoimmune hepatitis: a clinical-practice approach","author":"Terziroli Beretta-Piccoli","year":"2017","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.jaut.2018.10.004_bib22","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1136\/ard.2009.127100","article-title":"ANA screening: an old test with new recommendations","volume":"69","author":"Meroni","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2018.10.004_bib23","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/annrheumdis-2013-203863","article-title":"International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies","volume":"73","author":"Agmon-Levin","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2018.10.004_bib24","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/hep.510260306","article-title":"Antibodies to single-stranded and double-stranded DNA in antinuclear antibody-positive type 1-autoimmune hepatitis","volume":"26","author":"Czaja","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2018.10.004_bib25","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1440-1746.1998.tb00673.x","article-title":"Characterization of anti-histone antibodies in patients with type 1 autoimmune hepatitis","volume":"13","author":"Chen","year":"1998","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jaut.2018.10.004_bib26","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/0168-8278(95)80308-4","article-title":"Frequency and significance of antibodies to histones in autoimmune hepatitis","volume":"23","author":"Czaja","year":"1995","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jaut.2018.10.004_bib27","article-title":"Autoimmune hepatitis with anti centromere antibodies","volume":"2013","author":"Lodh","year":"2013","journal-title":"Case Rep. Immunol."},{"key":"10.1016\/j.jaut.2018.10.004_bib28","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S0168-8278(96)80290-X","article-title":"Identification of cyclin A as a molecular target of antinuclear antibodies (ANA) in hepatic and non-hepatic autoimmune diseases","volume":"25","author":"Strassburg","year":"1996","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jaut.2018.10.004_bib29","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/0016-5085(94)90078-7","article-title":"Patterns of nuclear immunofluorescence and reactivities to recombinant nuclear antigens in autoimmune hepatitis","volume":"107","author":"Czaja","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2018.10.004_bib31","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.3748\/wjg.14.3374","article-title":"Autoimmune liver serology: current diagnostic and clinical challenges","volume":"14","author":"Bogdanos","year":"2008","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.jaut.2018.10.004_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2018.07.006","article-title":"Autoimmune liver disease serology in acute hepatitis E virus infection","author":"Terziroli Beretta-Piccoli","year":"2018","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2018.10.004_bib33","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1177\/000992280404300709","article-title":"Frequency of antinuclear antibodies in healthy children and adolescents","volume":"43","author":"Hil\u00e1rio","year":"2004","journal-title":"Clin. Pediatr. (Phila)"},{"key":"10.1016\/j.jaut.2018.10.004_bib34","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1002\/art.1780400909","article-title":"Range of antinuclear antibodies in \u201chealthy\u201d individuals","volume":"40","author":"Tan","year":"1997","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2018.10.004_bib35","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1136\/gutjnl-2016-313369","article-title":"Drug-induced liver injury: recent advances in diagnosis and risk assessment","volume":"66","author":"Kullak-Ublick","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.jaut.2018.10.004_bib36","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/hep4.1039","article-title":"Atovaquone\/proguanil-induced autoimmune-like hepatitis","volume":"1","author":"Terziroli Beretta-Piccoli","year":"2017","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.jaut.2018.10.004_bib37","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S1089-3261(03)00104-1","article-title":"Antimitochondrial and other autoantibodies","volume":"7","author":"Bogdanos","year":"2003","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.jaut.2018.10.004_bib38","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1055\/s-0034-1383732","article-title":"Clinical significance of autoantibodies in primary biliary cirrhosis","volume":"34","author":"Nakamura","year":"2014","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.jaut.2018.10.004_bib39","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/s12016-010-8234-y","article-title":"Overcoming a \u201cprobable\u201d diagnosis in antimitochondrial antibody negative primary biliary cirrhosis: study of 100 sera and review of the literature","volume":"42","author":"Bizzaro","year":"2012","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.jaut.2018.10.004_bib40","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1038\/ajg.2009.126","article-title":"The serological profile of the autoimmune hepatitis\/primary biliary cirrhosis overlap syndrome","volume":"104","author":"Muratori","year":"2009","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.jaut.2018.10.004_bib41","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/MEG.0b013e328350f95b","article-title":"Autoimmune hepatitis\/primary biliary cirrhosis overlap syndrome and associated extrahepatic autoimmune diseases","volume":"24","author":"Efe","year":"2012","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jaut.2018.10.004_bib42","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1586\/erm.11.82","article-title":"Antinuclear antibodies as ancillary markers in primary biliary cirrhosis","volume":"12","author":"Granito","year":"2012","journal-title":"Expert Rev. Mol. Diagn"},{"key":"10.1016\/j.jaut.2018.10.004_bib43","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.clinre.2013.04.005","article-title":"Diagnostic and clinical significance of anti-centromere antibodies in primary biliary cirrhosis","volume":"37","author":"Liberal","year":"2013","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"10.1016\/j.jaut.2018.10.004_bib44","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/1529-0131(199904)42:3<455::AID-ANR10>3.0.CO;2-3","article-title":"A critical evaluation of enzyme immunoassays for detection of antinuclear autoantibodies of defined specificities. I. Precision, sensitivity, and specificity","volume":"42","author":"Tan","year":"1999","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2018.10.004_bib45","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.2169\/internalmedicine.31.1348","article-title":"Anti-centromere antibody and CREST syndrome in patients with primary biliary cirrhosis","volume":"31","author":"Shoji","year":"1992","journal-title":"Intern. Med."},{"key":"10.1016\/j.jaut.2018.10.004_bib46","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1136\/ard.60.11.1046","article-title":"Rheumatic disorders and primary biliary cirrhosis: an appraisal of 170 Italian patients","volume":"60","author":"Marasini","year":"2001","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2018.10.004_bib47","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/hep.21472","article-title":"Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis","volume":"45","author":"Nakamura","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2018.10.004_bib48","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10238-008-0150-6","article-title":"The value of antinuclear antibodies in primary biliary cirrhosis","volume":"8","author":"Gao","year":"2008","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.jaut.2018.10.004_bib49","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/j.1365-2036.2007.03433.x","article-title":"Antibodies to SS-A\/Ro-52kD and centromere in autoimmune liver disease: a clue to diagnosis and prognosis of primary biliary cirrhosis","volume":"26","author":"Granito","year":"2007","journal-title":"Aliment Pharmacol. Ther."},{"key":"10.1016\/j.jaut.2018.10.004_bib50","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1002\/hep.21172","article-title":"Correlation of initial autoantibody profile and clinical outcome in primary biliary cirrhosis","volume":"43","author":"Wesierska-Gadek","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2018.10.004_bib51","first-page":"1123","article-title":"Prevalence, kinetics, and therapeutic modulation of autoantibodies against Sp100 and promyelocytic leukemia protein in a large cohort of patients with primary biliary cirrhosis","volume":"26","author":"Z\u00fcchner","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2018.10.004_bib52","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.cca.2012.03.020","article-title":"Diagnostic and clinical utility of antibodies against the nuclear body promyelocytic leukaemia and Sp100 antigens in patients with primary biliary cirrhosis","volume":"413","author":"Mytilinaiou","year":"2012","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.jaut.2018.10.004_bib53","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1136\/gut.2003.036558","article-title":"Prevalence and clinical significance of isotype specific antinuclear antibodies in primary biliary cirrhosis","volume":"54","author":"Rigopoulou","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.jaut.2018.10.004_bib54","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1111\/j.1478-3231.2007.01586.x","article-title":"Antimitochondrial antibodies of immunoglobulin G3 subclass are associated with a more severe disease course in primary biliary cirrhosis","volume":"27","author":"Rigopoulou","year":"2007","journal-title":"Liver Int."},{"key":"10.1016\/j.jaut.2018.10.004_bib55","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S1590-8658(03)00466-3","article-title":"Association between the primary biliary cirrhosis specific anti-sp100 antibodies and recurrent urinary tract infection","volume":"35","author":"Bogdanos","year":"2003","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.jaut.2018.10.004_bib56","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1440-1746.1998.01553.x","article-title":"Autoantibodies against a 210 kDa glycoprotein of the nuclear pore complex as a prognostic marker in patients with primary biliary cirrhosis","volume":"13","author":"Itoh","year":"1998","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jaut.2018.10.004_bib57","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.510230512","article-title":"Specificity and sensitivity of gp210 autoantibodies detected using an enzyme-linked immunosorbent assay and a synthetic polypeptide in the diagnosis of primary biliary cirrhosis","volume":"23","author":"Bandin","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2018.10.004_bib58","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.3748\/wjg.14.3781","article-title":"Autoantibodies in primary sclerosing cholangitis","volume":"14","author":"Hov","year":"2008","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.jaut.2018.10.004_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cca.2015.07.021","article-title":"Autoantibodies to asialoglycoprotein receptor (ASGPR) in patients with autoimmune liver diseases","volume":"450","author":"Villalta","year":"2015","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.jaut.2018.10.004_bib60","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S0140-6736(65)92505-5","article-title":"Antibody to smooth muscle in patients with liver disease","volume":"2","author":"Johnson","year":"1965","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2018.10.004_bib61","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0016-5085(19)34365-3","article-title":"Smooth muscle autoantibody in \u201cautoimmune\u201d hepatitis","volume":"51","author":"Whittingham","year":"1966","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2018.10.004_bib62","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/S0140-6736(66)92131-3","article-title":"Autoimmune hepatitis. Immunofluorescence reactions with cytoplasm of smooth muscle and renal glomerular cells","volume":"1","author":"Whittingham","year":"1966","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2018.10.004_bib63","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/j.1749-6632.1965.tb19000.x","article-title":"Autoimmune hepatitis","volume":"124","author":"Mackay","year":"1965","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jaut.2018.10.004_bib64","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1136\/jcp.29.5.403","article-title":"Classification of smooth muscle autoantibodies detected by immunofluorescence","volume":"29","author":"Bottazzo","year":"1976","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.jaut.2018.10.004_bib65","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/hep.510260305","article-title":"Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on the disease profile","volume":"26","author":"Cassani","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2018.10.004_bib66","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1080\/0891693021000054066","article-title":"Smooth muscle antibodies and type 1 autoimmune hepatitis","volume":"35","author":"Muratori","year":"2002","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jaut.2018.10.004_bib67","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.autrev.2016.03.001","article-title":"Do anti-smooth muscle antibodies predict development of autoimmune hepatitis in patients with normal liver function? - a retrospective cohort review","volume":"15","author":"Healey","year":"2016","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2018.10.004_bib68","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1136\/jcp.2006.039404","article-title":"Diagnostic relevance of anti-filamentous actin antibodies in autoimmune hepatitis","volume":"60","author":"Liaskos","year":"2007","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.jaut.2018.10.004_bib69","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1136\/jcp.2005.027367","article-title":"Antibodies to filamentous actin (F-actin) in type 1 autoimmune hepatitis","volume":"59","author":"Granito","year":"2006","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.jaut.2018.10.004_bib70","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1111\/j.1572-0241.2006.00830.x","article-title":"Evaluation of F-actin ELISA for the diagnosis of autoimmune hepatitis","volume":"101","author":"Frenzel","year":"2006","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.jaut.2018.10.004_bib71","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1080\/08916930701619896","article-title":"Diagnostic accuracy of four different immunological methods for the detection of anti-F-actin autoantibodies in type 1 autoimmune hepatitis and other liver-related disorders","volume":"41","author":"Villalta","year":"2008","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jaut.2018.10.004_bib72","first-page":"621","article-title":"Smooth muscle autoantibodies and autoantigens","volume":"38","author":"Toh","year":"1979","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jaut.2018.10.004_bib73","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/0090-1229(78)90141-1","article-title":"Smooth muscle antibodies of actin and \u201cnon-actin\u201d specificity","volume":"9","author":"Kurki","year":"1978","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1016\/j.jaut.2018.10.004_bib74","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0090-1229(78)90165-4","article-title":"Characterization of human smooth muscle autoantibodies reacting with cytoplasmic intermediate filaments","volume":"11","author":"Kurki","year":"1978","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1016\/j.jaut.2018.10.004_bib75","first-page":"266","article-title":"Anti-actin specificity of human smooth muscle antibodies in chronic active hepatitis","volume":"24","author":"Lidman","year":"1976","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jaut.2018.10.004_bib76","first-page":"473","article-title":"Human smooth muscle autoantibody. Its identification as antiactin antibody and a study of its binding to \u201cnonmuscular\u201d cells","volume":"72","author":"Gabbiani","year":"1973","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jaut.2018.10.004_bib77","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1002\/hep.510240515","article-title":"Frequency and significance of antibodies to actin in type 1 autoimmune hepatitis","volume":"24","author":"Czaja","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2018.10.004_bib78","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/jcla.10040","article-title":"Anti-smooth muscle antibodies (ASMAs) and anti-cytoskeleton antibodies (ACTAs) in liver diseases: a comparison of classical indirect immunofluorescence with ELISA","volume":"16","author":"Zamanou","year":"2002","journal-title":"J. Clin. Lab. Anal."},{"key":"10.1016\/j.jaut.2018.10.004_bib79","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1080\/0891693021000056721","article-title":"Organ and non-organ specific autoantibody titres and IgG levels as markers of disease activity: a longitudinal study in childhood autoimmune liver disease","volume":"35","author":"Gregorio","year":"2002","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jaut.2018.10.004_bib80","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/hep.26666","article-title":"Antismooth muscle and antiactin antibodies are indirect markers of histological and biochemical activity of autoimmune hepatitis","volume":"59","author":"Couto","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2018.10.004_bib81","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.cld.2015.08.008","article-title":"Sclerosing cholangitis in children and adolescents","volume":"20","author":"Mieli-Vergani","year":"2016","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.jaut.2018.10.004_bib82","first-page":"331","article-title":"Microsomal antibodies in active chronic hepatitis and other disorders","volume":"15","author":"Rizzetto","year":"1973","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jaut.2018.10.004_bib83","first-page":"589","article-title":"Characterization of the microsomal antigen related to a subclass of active chronic hepatitis","volume":"26","author":"Rizzetto","year":"1974","journal-title":"Immunology"},{"key":"10.1016\/j.jaut.2018.10.004_bib84","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1136\/bmj.2.5910.80","article-title":"Hepatic disorders associated with liver-kidney microsomal antibodies","volume":"2","author":"Smith","year":"1974","journal-title":"Br. Med. J."},{"key":"10.1016\/j.jaut.2018.10.004_bib85","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/hep.1840070626","article-title":"Chronic active hepatitis associated with antiliver\/kidney microsome antibody type 1: a second type of \u201cautoimmune\u201d hepatitis","volume":"7","author":"Homberg","year":"1987","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2018.10.004_bib86","first-page":"666","article-title":"[Chronic hepatitis: interest of a classification based on the presence or the absence of HBs Ag, smooth muscle antibody and microsomal antibody (author's transl)]","volume":"4","author":"Poupon","year":"1980","journal-title":"Gastroenterol. Clin. Biol."},{"key":"10.1016\/j.jaut.2018.10.004_bib87","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jaut.2012.11.002","article-title":"Autoimmune hepatitis: a comprehensive review","volume":"41","author":"Liberal","year":"2013","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2018.10.004_bib88","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/hep.510250308","article-title":"Autoimmune hepatitis in childhood: a 20-year experience","volume":"25","author":"Gregorio","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2018.10.004_bib89","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jaut.2013.08.004","article-title":"Autoimmune hepatitis: contrasts and comparisons in children and adults - a comprehensive review","volume":"46","author":"Floreani","year":"2013","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2018.10.004_bib90","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1136\/jcp.55.12.906","article-title":"Detection of liver kidney microsomal type 1 antibody using molecularly based immunoassays","volume":"55","author":"Kerkar","year":"2002","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.jaut.2018.10.004_bib91","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1172\/JCI113949","article-title":"Major antigen of liver kidney microsomal autoantibodies in idiopathic autoimmune hepatitis is cytochrome P450db1","volume":"83","author":"Manns","year":"1989","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jaut.2018.10.004_bib92","doi-asserted-by":"crossref","first-page":"8256","DOI":"10.1073\/pnas.85.21.8256","article-title":"Antibodies against human cytochrome P-450db1 in autoimmune hepatitis type II","volume":"85","author":"Zanger","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.jaut.2018.10.004_bib93","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1084\/jem.168.2.801","article-title":"Anti-liver kidney microsome antibody recognizes a cytochrome P450 from the IID subfamily","volume":"168","author":"Gueguen","year":"1988","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jaut.2018.10.004_bib94","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.4049\/jimmunol.170.3.1481","article-title":"Cytochrome P4502D6(193-212): a new immunodominant epitope and target of virus\/self cross-reactivity in liver kidney microsomal autoantibody type 1-positive liver disease","volume":"170","author":"Kerkar","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2018.10.004_bib95","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S0168-8278(99)80092-0","article-title":"Epitope mapping of cytochrome P4502D6 autoantigen in patients with chronic hepatitis C during alpha-interferon treatment","volume":"30","author":"Dalekos","year":"1999","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jaut.2018.10.004_bib96","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1172\/JCI115443","article-title":"LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monooxygenase","volume":"88","author":"Manns","year":"1991","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jaut.2018.10.004_bib97","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1016\/0016-5085(93)90657-X","article-title":"Characterization of anti-liver-kidney microsome antibody (anti-LKM1) from hepatitis C virus-positive and -negative sera","volume":"104","author":"Yamamoto","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2018.10.004_bib98","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1172\/JCI64413","article-title":"Pemphigus autoantibodies generated through somatic mutations target the desmoglein-3 cis-interface","volume":"122","author":"Di Zenzo","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jaut.2018.10.004_bib99","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1136\/gut.46.4.553","article-title":"Liver\/kidney microsomal antibody type 1 targets CYP2D6 on hepatocyte plasma membrane","volume":"46","author":"Muratori","year":"2000","journal-title":"Gut"},{"key":"10.1016\/j.jaut.2018.10.004_bib100","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/hep.1840040223","article-title":"Ticrynafen-associated hepatic injury: analysis of 340 cases","volume":"4","author":"Zimmerman","year":"1984","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2018.10.004_bib101","first-page":"561","article-title":"A new anti-liver-kidney microsome antibody (anti-LKM2) in tienilic acid-induced hepatitis","volume":"55","author":"Homberg","year":"1984","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jaut.2018.10.004_bib102","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1073\/pnas.84.2.551","article-title":"Human anti-endoplasmic reticulum autoantibodies appearing in a drug-induced hepatitis are directed against a human liver cytochrome P-450 that hydroxylates the drug","volume":"84","author":"Beaune","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.jaut.2018.10.004_bib103","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0026-895X(25)09234-X","article-title":"Tienilic acid-induced autoimmune hepatitis: anti-liver and-kidney microsomal type 2 autoantibodies recognize a three-site conformational epitope on cytochrome P4502C9","volume":"50","author":"Lecoeur","year":"1996","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.jaut.2018.10.004_bib104","first-page":"232","article-title":"Microsomal autoantibodies in chronic infection with the HBsAg associated delta (delta) agent","volume":"54","author":"Crivelli","year":"1983","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jaut.2018.10.004_bib105","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/S0016-5085(96)70020-3","article-title":"Autoantibodies against glucuronosyltransferases differ between viral hepatitis and autoimmune hepatitis","volume":"111","author":"Strassburg","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2018.10.004_bib106","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S0140-6736(94)91966-6","article-title":"Recognition of uridine diphosphate glucuronosyl transferases by LKM-3 antibodies in chronic hepatitis D","volume":"344","author":"Philipp","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2018.10.004_bib107","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/j.1572-0241.2001.03383.x","article-title":"LKM3 autoantibodies in hepatitis C cirrhosis: a further phenomenon of the HCV-induced autoimmunity","volume":"96","author":"Csepregi","year":"2001","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.jaut.2018.10.004_bib108","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1740-2557-1-2","article-title":"Autoantibodies and autoantigens in autoimmune hepatitis: important tools in clinical practice and to study pathogenesis of the disease","volume":"1","author":"Zachou","year":"2004","journal-title":"J. Autoimmune Dis."},{"key":"10.1016\/j.jaut.2018.10.004_bib109","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgast-2018-000203","article-title":"Autoantibodies in chronic hepatitis C virus infection: impact on clinical outcomes and extrahepatic manifestations","volume":"5","author":"Gilman","year":"2018","journal-title":"BMJ Open Gastroenterol."},{"key":"10.1016\/j.jaut.2018.10.004_bib110","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1136\/gut.37.3.406","article-title":"Heterogeneity of liver\/kidney microsomal antibody type 1 in autoimmune hepatitis and hepatitis C virus related liver disease","volume":"37","author":"Muratori","year":"1995","journal-title":"Gut"},{"key":"10.1016\/j.jaut.2018.10.004_bib111","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1177\/039463200401700112","article-title":"Multiple viral\/self immunological cross-reactivity in liver kidney microsomal antibody positive hepatitis C virus infected patients is associated with the possession of HLA B51","volume":"17","author":"Bogdanos","year":"2004","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"10.1016\/j.jaut.2018.10.004_bib112","doi-asserted-by":"crossref","first-page":"S169","DOI":"10.1097\/00005176-200406001-00419","article-title":"P0295 Virus-self crossreactivity inducing de novo autoimmune hepatitis eight-years after liver transplantation","volume":"39","author":"Bogdanos","year":"2004","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.jaut.2018.10.004_bib113","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0168-8278(05)80395-2","article-title":"Interferon therapy in liver\/kidney microsomal antibody type 1-positive patients with chronic hepatitis C","volume":"21","author":"Muratori","year":"1994","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jaut.2018.10.004_bib114","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/S0016-5085(98)70484-6","article-title":"Two cytochromes P450 are major hepatocellular autoantigens in autoimmune polyglandular syndrome type 1","volume":"114","author":"Clemente","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2018.10.004_bib115","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1002\/hep.1840080632","article-title":"Antibody to liver cytosol (anti-LC1) in patients with autoimmune chronic active hepatitis type 2","volume":"8","author":"Martini","year":"1988","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2018.10.004_bib116","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0016-5085(99)70186-1","article-title":"Formiminotransferase cyclodeaminase is an organ-specific autoantigen recognized by sera of patients with autoimmune hepatitis","volume":"116","author":"Lapierre","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2018.10.004_bib117","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1053\/jhep.2001.27179","article-title":"Distinct epitopes on formiminotransferase cyclodeaminase induce autoimmune liver cytosol antibody type 1","volume":"34","author":"Muratori","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2018.10.004_bib118","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/jcla.21813","article-title":"Autoantibody profiling in a cohort of pediatric and adult patients with autoimmune hepatitis","volume":"30","author":"Villalta","year":"2016","journal-title":"J. Clin. Lab. Anal."},{"key":"10.1016\/j.jaut.2018.10.004_bib119","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1136\/gut.36.5.749","article-title":"Liver cytosolic 1 antigen-antibody system in type 2 autoimmune hepatitis and hepatitis C virus infection","volume":"36","author":"Lenzi","year":"1995","journal-title":"Gut"},{"key":"10.1016\/j.jaut.2018.10.004_bib120","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1740-2557-4-2","article-title":"Autoimmune hepatitis-specific antibodies against soluble liver antigen and liver cytosol type 1 in patients with chronic viral hepatitis","volume":"4","author":"Rigopoulou","year":"2007","journal-title":"J. Autoimmune Dis."},{"key":"10.1016\/j.jaut.2018.10.004_bib121","first-page":"58","article-title":"Anti-liver cytosolic antigen type 1 (LC1) antibodies in childhood autoimmune liver disease","volume":"21","author":"Han","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2018.10.004_bib122","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1136\/gut.42.5.721","article-title":"Liver\/kidney microsomal antibody type 1 and liver cytosol antibody type 1 concentrations in type 2 autoimmune hepatitis","volume":"42","author":"Muratori","year":"1998","journal-title":"Gut"},{"key":"10.1016\/j.jaut.2018.10.004_bib123","first-page":"921","article-title":"Hypergammaglobulin\u00e4mische chronisch aktive Hepatitis mit Nachweis von Leber-Pankreas-spezifischen komplementbindenden Autoantik\u00f6rpern","volume":"87","author":"Berg","year":"1981","journal-title":"Verh. Dtsch. Ges. Inn. Med."},{"key":"10.1016\/j.jaut.2018.10.004_bib124","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0140-6736(87)90443-0","article-title":"Serological definition of new subgroup of patients with autoimmune chronic active hepatitis","volume":"1","author":"Stechemesser","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2018.10.004_bib125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hep.1840180102","article-title":"Characterization and clinical relevance of liver-pancreas antibodies in autoimmune hepatitis","volume":"18","author":"Stechemesser","year":"1993","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2018.10.004_bib126","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0140-6736(87)92024-1","article-title":"Characterisation of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against a soluble liver antigen","volume":"1","author":"Manns","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2018.10.004_bib127","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/S0140-6736(00)02166-8","article-title":"Identification of target antigen for SLA\/LP autoantibodies in autoimmune hepatitis","volume":"355","author":"Wies","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2018.10.004_bib128","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1136\/gut.51.2.259","article-title":"Establishment of standardised SLA\/LP immunoassays: specificity for autoimmune hepatitis, worldwide occurrence, and clinical characteristics","volume":"51","author":"Baeres","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.jaut.2018.10.004_bib129","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1046\/j.1365-2249.2000.01280.x","article-title":"Isolation and characterization of cDNA encoding the antigenic protein of the human tRNP(Ser)Sec complex recognized by autoantibodies from patients with type-1 autoimmune hepatitis","volume":"121","author":"Costa","year":"2000","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jaut.2018.10.004_bib130","article-title":"Meta-analysis: diagnostic accuracy of antinuclear antibodies, smooth muscle antibodies and antibodies to a soluble liver antigen\/liver pancreas in autoimmune hepatitis","volume":"9","author":"Zhang","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.jaut.2018.10.004_bib131","doi-asserted-by":"crossref","first-page":"18017","DOI":"10.1038\/nrdp.2018.17","article-title":"Autoimmune hepatitis","volume":"4","author":"Mieli-Vergani","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.jaut.2018.10.004_bib132","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/08916930410001686260","article-title":"Anti-soluble liver antigen (SLA) antibodies in chronic HCV infection","volume":"37","author":"Vitozzi","year":"2004","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jaut.2018.10.004_bib133","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1053\/jhep.2001.22218","article-title":"Soluble liver antigen: isolation of a 35-kd recombinant protein (SLA-p35) specifically recognizing sera from patients with autoimmune hepatitis","volume":"33","author":"Volkmann","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2018.10.004_bib134","doi-asserted-by":"crossref","first-page":"9739","DOI":"10.1073\/pnas.89.20.9739","article-title":"Autoantibodies against a serine tRNA-protein complex implicated in cotranslational selenocysteine insertion","volume":"89","author":"Gelpi","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.jaut.2018.10.004_bib135","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1053\/jhep.2002.32092","article-title":"Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver disease","volume":"35","author":"Ma","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2018.10.004_bib136","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1053\/jhep.2002.30699","article-title":"Fine specificity of autoantibodies to soluble liver antigen and liver\/pancreas","volume":"35","author":"Herkel","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2018.10.004_bib137","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1053\/j.gastro.2008.07.029","article-title":"Identification of CD4 T-cell epitopes in soluble liver antigen\/liver pancreas autoantigen in autoimmune hepatitis","volume":"135","author":"Mix","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2018.10.004_bib138","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/liv.12658","article-title":"Anti-SLA\/LP alone or in combination with anti-Ro52 and fine specificity of anti-Ro52 antibodies in patients with autoimmune hepatitis","volume":"35","author":"Zachou","year":"2015","journal-title":"Liver Int."},{"key":"10.1016\/j.jaut.2018.10.004_bib139","unstructured":"https:\/\/doi.org.10.1016\/S0168-8278(07)62258-2 - pdf n.d. http:\/\/www.journal-of-hepatology.eu\/article\/S0168-8278(07)62258-2\/pdf (Accessed August 30, 2017)."},{"key":"10.1016\/j.jaut.2018.10.004_bib140","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/j.1572-0241.2006.00479.x","article-title":"Pregnancy in autoimmune hepatitis: outcome and risk factors","volume":"101","author":"Schramm","year":"2006","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.jaut.2018.10.004_bib141","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s12016-017-8653-0","article-title":"Neonatal systemic lupus erythematosus syndrome: a comprehensive review","volume":"53","author":"Vanoni","year":"2017","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.jaut.2018.10.004_bib142","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.autrev.2012.04.005","article-title":"Asialoglycoprotein receptor (ASGPR) as target autoantigen in liver autoimmunity: lost and found","volume":"12","author":"Rigopoulou","year":"2012","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2018.10.004_bib143","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/9780470122860.ch3","article-title":"The role of surface carbohydrates in the hepatic recognition and transport of circulating glycoproteins","volume":"41","author":"Ashwell","year":"1974","journal-title":"Adv. Enzymol. Relat. Area Mol. Biol."},{"key":"10.1016\/j.jaut.2018.10.004_bib144","doi-asserted-by":"crossref","first-page":"7260","DOI":"10.1016\/S0021-9258(19)42100-5","article-title":"Structure of the carbohydrate units of IgA1 immunoglobulin. I. Composition, glycopeptide isolation, and structure of the asparagine-linked oligosaccharide units","volume":"249","author":"Baenziger","year":"1974","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jaut.2018.10.004_bib145","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s00705-010-0657-5","article-title":"Fibronectin and asialoglyprotein receptor mediate hepatitis B surface antigen binding to the cell surface","volume":"155","author":"Yang","year":"2010","journal-title":"Arch. Virol."},{"key":"10.1016\/j.jaut.2018.10.004_bib146","doi-asserted-by":"crossref","first-page":"10950","DOI":"10.1128\/JVI.74.23.10950-10957.2000","article-title":"Hepatitis A virus-specific immunoglobulin A mediates infection of hepatocytes with hepatitis A virus via the asialoglycoprotein receptor","volume":"74","author":"Dotzauer","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.jaut.2018.10.004_bib147","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1002\/hep.24477","article-title":"Hepatocyte cytotoxicity is facilitated by asialoglycoprotein receptor","volume":"54","author":"Guy","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2018.10.004_bib148","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/S0140-6736(84)91167-X","article-title":"Antibodies to liver-specific protein predict outcome of treatment withdrawal in autoimmune chronic active hepatitis","volume":"2","author":"McFarlane","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2018.10.004_bib149","first-page":"347","article-title":"Identification of the hepatic asialo-glycoprotein receptor (hepatic lectin) as a component of liver specific membrane lipoprotein (LSP)","volume":"55","author":"McFarlane","year":"1984","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jaut.2018.10.004_bib150","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0168-8278(87)80548-2","article-title":"Liver cell damage caused by monoclonal antibody against an organ-specific membrane antigen in vivo and in vitro","volume":"4","author":"Poralla","year":"1987","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jaut.2018.10.004_bib151","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1002\/hep.1840120611","article-title":"The human hepatic asialoglycoprotein receptor is a target antigen for liver-infiltrating T cells in autoimmune chronic active hepatitis and primary biliary cirrhosis","volume":"12","author":"L\u00f6hr","year":"1990","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2018.10.004_bib152","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1365-2249.1992.tb03037.x","article-title":"Liver-infiltrating T helper cells in autoimmune chronic active hepatitis stimulate the production of autoantibodies against the human asialoglycoprotein receptor in vitro","volume":"88","author":"L\u00f6hr","year":"1992","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jaut.2018.10.004_bib153","first-page":"527","article-title":"Relation between autoimmune liver diseases and viral hepatitis: clinical and serological characteristics in 859 patients","volume":"33","author":"Lohse","year":"1995","journal-title":"Z. Gastroenterol."},{"key":"10.1016\/j.jaut.2018.10.004_bib154","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1002\/hep.23584","article-title":"Diagnosis and management of autoimmune hepatitis","volume":"51","author":"Manns","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2018.10.004_bib155","first-page":"103","article-title":"Autoreactivity to hepatocellular antigens in primary biliary cirrhosis and primary sclerosing cholangitis","volume":"30","author":"Bedlow","year":"1989","journal-title":"J. Clin. Lab. Immunol."},{"key":"10.1016\/j.jaut.2018.10.004_bib156","first-page":"99","article-title":"Anti-asialoglycoprotein receptor autoantibodies, detected by a capture-immunoassay, are associated with autoimmune liver diseases","volume":"56","author":"Yoshioka","year":"2002","journal-title":"Acta Med. Okayama"},{"key":"10.1016\/j.jaut.2018.10.004_bib157","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0140-6736(85)91147-X","article-title":"Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis","volume":"1","author":"van der Woude","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2018.10.004_bib158","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJM198806233182504","article-title":"Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis","volume":"318","author":"Falk","year":"1988","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2018.10.004_bib159","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1136\/bmj.285.6342.606","article-title":"Segmental necrotising glomerulonephritis with antineutrophil antibody: possible arbovirus aetiology?","volume":"285","author":"Davies","year":"1982","journal-title":"Br. Med. J. (Clin. Res. Ed.)"},{"key":"10.1016\/j.jaut.2018.10.004_bib160","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1007\/s12016-017-8616-5","article-title":"Cutaneous manifestations of ANCA-associated small vessels vasculitis","volume":"53","author":"Marzano","year":"2017","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.jaut.2018.10.004_bib161","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1053\/gast.2000.9366","article-title":"\u201cAtypical p-ANCA\u201d in IBD and hepatobiliary disorders react with a 50-kilodalton nuclear envelope protein of neutrophils and myeloid cell lines","volume":"119","author":"Terjung","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2018.10.004_bib162","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/hep.510280207","article-title":"Atypical antineutrophil cytoplasmic antibodies with perinuclear fluorescence in chronic inflammatory bowel diseases and hepatobiliary disorders colocalize with nuclear lamina proteins","volume":"28","author":"Terjung","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2018.10.004_bib163","first-page":"979","article-title":"Nuclear localization of the antigen detected by ulcerative colitis-associated perinuclear antineutrophil cytoplasmic antibodies","volume":"147","author":"Billing","year":"1995","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jaut.2018.10.004_bib164","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.clinre.2012.07.008","article-title":"Antineutrophil cytoplasmic auto-antibodies (ANCA) in autoimmune hepatitis and primary sclerosing cholangitis","volume":"37","author":"Deniziaut","year":"2013","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"10.1016\/j.jaut.2018.10.004_bib165","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/0016-5085(91)70028-V","article-title":"Neutrophil cytoplasmic antibodies: a link between primary sclerosing cholangitis and ulcerative colitis","volume":"100","author":"Duerr","year":"1991","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2018.10.004_bib166","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1136\/gut.33.5.657","article-title":"Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis","volume":"33","author":"Seibold","year":"1992","journal-title":"Gut"},{"key":"10.1016\/j.jaut.2018.10.004_bib167","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/0016-5085(95)90215-5","article-title":"High-titer antineutrophil cytoplasmic antibodies in type-1 autoimmune hepatitis","volume":"108","author":"Targan","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2018.10.004_bib168","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/hep.510250510","article-title":"Anti-neutrophil cytoplasmic antibodies in type 1 and 2 autoimmune hepatitis","volume":"25","author":"Zauli","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2018.10.004_bib169","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1093\/ajcp\/99.3.277","article-title":"Antineutrophil cytoplasmic antibody in inflammatory bowel and hepatobiliary diseases. High prevalence in ulcerative colitis, primary sclerosing cholangitis, and autoimmune hepatitis","volume":"99","author":"Hardarson","year":"1993","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.jaut.2018.10.004_bib170","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/hep.1840170310","article-title":"Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver diseases","volume":"17","author":"Mulder","year":"1993","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2018.10.004_bib171","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1136\/gut.2008.157818","article-title":"p-ANCAs in autoimmune liver disorders recognise human beta-tubulin isotype 5 and cross-react with microbial protein FtsZ","volume":"59","author":"Terjung","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.jaut.2018.10.004_bib172","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s12016-008-8088-8","article-title":"Atypical p-ANCA in PSC and AIH: a hint toward a \u201cleaky gut\u201d?","volume":"36","author":"Terjung","year":"2009","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.jaut.2018.10.004_bib173","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1053\/j.gastro.2008.01.042","article-title":"The natural history of small-duct primary sclerosing cholangitis","volume":"134","author":"Bj\u00f6rnsson","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2018.10.004_bib174","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1440-1746.1994.tb01214.x","article-title":"Anti-neutrophil cytoplasmic antibody: a prognostic indicator in primary sclerosing cholangitis","volume":"9","author":"Pokorny","year":"1994","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jaut.2018.10.004_bib175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0112877","article-title":"PR3-ANCA: a promising biomarker in primary sclerosing cholangitis (PSC)","volume":"9","author":"Stinton","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.jaut.2018.10.004_bib176","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/S0168-8278(00)80241-X","article-title":"Clinical significance of anti-neutrophil cytoplasmic antibodies (ANCA) in autoimmune liver diseases","volume":"32","author":"Roozendaal","year":"2000","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jaut.2018.10.004_bib177","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1056\/NEJM195801232580407","article-title":"Primary biliary cirrhosis showing a high titer of autoantibody; report of a case","volume":"258","author":"Mackay","year":"1958","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2018.10.004_bib178","first-page":"12","article-title":"Characterization of auto-antibodies produced in the rabbit by the injection of rat liver","volume":"43","author":"Asherson","year":"1962","journal-title":"Br. J. Exp. Pathol."},{"key":"10.1016\/j.jaut.2018.10.004_bib179","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0140-6736(65)91372-3","article-title":"Serological tests in diagnosis of primary biliary cirrhosis","volume":"1","author":"Walker","year":"1965","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2018.10.004_bib180","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1136\/jcp.19.6.527","article-title":"Serological and histological diagnosis of primary biliary cirrhosis","volume":"19","author":"Goudie","year":"1966","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.jaut.2018.10.004_bib181","doi-asserted-by":"crossref","first-page":"533","DOI":"10.7326\/0003-4819-77-4-533","article-title":"Mitochondrial antibody in primary biliary cirrhosis and other diseases","volume":"77","author":"Klatskin","year":"1972","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.jaut.2018.10.004_bib182","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1084\/jem.126.2.277","article-title":"Mitochondrial antibodies in primary biliary cirrhosis. I. Localization of the antigen to mitochondrial membranes","volume":"126","author":"Berg","year":"1967","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jaut.2018.10.004_bib183","first-page":"200","article-title":"Mitochondrial antibodies in primary biliary cirrhosis. II. The complement fixing antigen as a component of mitochondrial inner membranes","volume":"50","author":"Berg","year":"1969","journal-title":"Br. J. Exp. Pathol."},{"key":"10.1016\/j.jaut.2018.10.004_bib184","first-page":"281","article-title":"Mitochondrial antibodies in primary biliary cirrhosis. IV. Significance of membrane structure for the complement-fixing antigen","volume":"17","author":"Berg","year":"1969","journal-title":"Immunology"},{"key":"10.1016\/j.jaut.2018.10.004_bib185","first-page":"511","article-title":"Mitochondrial antibodies in primary biliary cirrhosis. 3. Characterization of the inner-membrane complement fixing antigen","volume":"4","author":"Berg","year":"1969","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jaut.2018.10.004_bib186","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/hep.1840050510","article-title":"Mitochondrial antibodies in primary biliary cirrhosis: species and nonspecies specific determinants of M2 antigen","volume":"5","author":"Lindenborn-Fotinos","year":"1985","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2018.10.004_bib187","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.4049\/jimmunol.135.3.1739","article-title":"Reactivity of anti-mitochondrial autoantibodies in primary biliary cirrhosis: definition of two novel mitochondrial polypeptide autoantigens","volume":"135","author":"Frazer","year":"1985","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2018.10.004_bib188","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/S0140-6736(82)91327-7","article-title":"ATPase-associated antigen (M2): marker antigen for serological diagnosis of primary biliary cirrhosis","volume":"2","author":"Berg","year":"1982","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2018.10.004_bib189","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/BF01728613","article-title":"Mitochondrial antigens and autoantibodies: from anti-M1 to anti-M9","volume":"64","author":"Berg","year":"1986","journal-title":"Klin. Wochenschr."},{"key":"10.1016\/j.jaut.2018.10.004_bib190","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.jhep.2008.06.006","article-title":"The unfinished business of primary biliary cirrhosis","volume":"49","author":"Selmi","year":"2008","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jaut.2018.10.004_bib191","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.4049\/jimmunol.138.10.3525","article-title":"Identification and specificity of a cDNA encoding the 70 kd mitochondrial antigen recognized in primary biliary cirrhosis","volume":"138","author":"Gershwin","year":"1987","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2018.10.004_bib192","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/hep.510240117","article-title":"Use of a designer triple expression hybrid clone for three different lipoyl domain for the detection of antimitochondrial autoantibodies","volume":"24","author":"Moteki","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2018.10.004_bib193","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.autrev.2014.01.041","article-title":"The diagnosis of primary biliary cirrhosis","volume":"13","author":"Bowlus","year":"2014","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2018.10.004_bib194","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1586\/14737159.2016.1164038","article-title":"A contemporary perspective on the molecular characteristics of mitochondrial autoantigens and diagnosis in primary biliary cholangitis","volume":"16","author":"Leung","year":"2016","journal-title":"Expert Rev. Mol. Diagn"},{"key":"10.1016\/j.jaut.2018.10.004_bib195","doi-asserted-by":"crossref","DOI":"10.1002\/hep.29245","article-title":"Autoreactive monoclonal antibodies from patients with primary biliary cholangitis recognize environmental xenobiotics","author":"Tanaka","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2018.10.004_bib196","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/s10875-007-9092-0","article-title":"Diagnostic relevance and clinical significance of the new enhanced performance M2 (MIT3) ELISA for the detection of IgA and IgG antimitochondrial antibodies in primary biliary cirrhosis","volume":"27","author":"Gabeta","year":"2007","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.jaut.2018.10.004_bib197","series-title":"Chapter 62 - Primary Biliary Cirrhosis. The Autoimmune Diseases","first-page":"909","author":"Selmi","year":"2014"},{"key":"10.1016\/j.jaut.2018.10.004_bib198","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1600-0676.1996.tb00722.x","article-title":"Antimitochondrial antibodies in patients with chronic hepatitis C","volume":"16","author":"Grimbert","year":"1996","journal-title":"Liver"},{"key":"10.1016\/j.jaut.2018.10.004_bib199","article-title":"Tuberculosis is not a risk factor for primary biliary cirrhosis: a review of the literature","volume":"2012","author":"Smyk","year":"2012","journal-title":"Tuberc. Res. Treat."},{"key":"10.1016\/j.jaut.2018.10.004_bib200","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/j.1365-2249.1993.tb03397.x","article-title":"Sera from patients with tuberculosis recognize the M2a-epitope (E2-subunit of pyruvate dehydrogenase) specific for primary biliary cirrhosis","volume":"92","author":"Klein","year":"1993","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jaut.2018.10.004_bib201","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/BF01541171","article-title":"Antimitochondrial (pyruvate dehydrogenase) antibodies in leprosy","volume":"14","author":"Gilburd","year":"1994","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.jaut.2018.10.004_bib202","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.jaut.2010.09.005","article-title":"PBC screen: an IgG\/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis","volume":"35","author":"Liu","year":"2010","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2018.10.004_bib203","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.jhep.2007.05.011","article-title":"The significance of autoantibodies and immunoglobulins in acute liver failure: a cohort study","volume":"47","author":"Bernal","year":"2007","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jaut.2018.10.004_bib204","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1002\/hep.1840060609","article-title":"Positive antimitochondrial antibody but normal alkaline phosphatase: is this primary biliary cirrhosis?","volume":"6","author":"Mitchison","year":"1986","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2018.10.004_bib205","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S0140-6736(96)04410-8","article-title":"Natural history of early primary biliary cirrhosis","volume":"348","author":"Metcalf","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2018.10.004_bib206","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s005350170111","article-title":"The follow-up of asymptomatic persons with antibodies to pyruvate dehydrogenase in adult population samples","volume":"36","author":"Kisand","year":"2001","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.jaut.2018.10.004_bib207","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/hep.28859","article-title":"Large-scale characterization study of patients with antimitochondrial antibodies but nonestablished primary biliary cholangitis","volume":"65","author":"Dahlqvist","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2018.10.004_bib208","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1016\/0016-5085(90)90488-M","article-title":"Primary biliary cirrhosis. Quantitation of autoantibodies to purified mitochondrial enzymes and correlation with disease progression","volume":"99","author":"Heseltine","year":"1990","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2018.10.004_bib209","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/0016-5085(80)90571-5","article-title":"Clinical pattern and course of disease in primary biliary cirrhosis based on an analysis of 236 patients","volume":"78","author":"Christensen","year":"1980","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2018.10.004_bib210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM198301063080101","article-title":"The prognostic importance of clinical and histologic features in asymptomatic and symptomatic primary biliary cirrhosis","volume":"308","author":"Roll","year":"1983","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2018.10.004_bib211","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hep.1840100102","article-title":"Prognosis in primary biliary cirrhosis: model for decision making","volume":"10","author":"Dickson","year":"1989","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2018.10.004_bib212","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s12072-012-9413-0","article-title":"Humoral autoimmune response heterogeneity in the spectrum of primary biliary cirrhosis","volume":"7","author":"Dellavance","year":"2013","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.jaut.2018.10.004_bib213","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1056\/NEJM199105303242204","article-title":"A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group","volume":"324","author":"Poupon","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2018.10.004_bib214","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/hep.510250103","article-title":"Quantitative measurement of autoantibodies to recombinant mitochondrial antigens in patients with primary biliary cirrhosis: relationship of levels of autoantibodies to disease progression","volume":"25","author":"Van Norstrand","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2018.10.004_bib215","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1111\/j.1572-0241.2002.05620.x","article-title":"Antimitochondrial antibody profiles: are they valid prognostic indicators in primary biliary cirrhosis?","volume":"97","author":"Joshi","year":"2002","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.jaut.2018.10.004_bib216","first-page":"129","article-title":"Serial analysis of antimitochondrial antibody in patients with primary biliary cirrhosis","volume":"11","author":"Benson","year":"2004","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.jaut.2018.10.004_bib217","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1309\/AJCPQV4A7QAEEFEV","article-title":"The significance of autoantibody changes over time in primary biliary cirrhosis","volume":"144","author":"Tana","year":"2015","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.jaut.2018.10.004_bib218","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.hepres.2005.03.017","article-title":"A case of acute hepatitis with positive autoantibodies who actually had hepatitis E virus infection","volume":"32","author":"Nagasaki","year":"2005","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.jaut.2018.10.004_bib219","article-title":"Acute hepatitis E presenting with clinical feature of autoimmune hepatitis","volume":"6","author":"Patel","year":"2016","journal-title":"J. Community Hosp. Intern. Med. Perspect."},{"key":"10.1016\/j.jaut.2018.10.004_bib220","doi-asserted-by":"crossref","first-page":"152","DOI":"10.4254\/wjh.v5.i3.152","article-title":"Case of acute hepatitis E with concomitant signs of autoimmunity","volume":"5","author":"Vieira","year":"2013","journal-title":"World J. Hepatol."},{"key":"10.1016\/j.jaut.2018.10.004_bib221","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.jhep.2012.08.001","article-title":"Transfusion-transmitted hepatitis E in a misleading context of autoimmunity and drug-induced toxicity","volume":"57","author":"Ha\u00efm-Boukobza","year":"2012","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jaut.2018.10.004_bib222","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1620\/tjem.235.275","article-title":"Clinical features of hepatitis E virus infection in Ibaraki, Japan: autochthonous hepatitis E and acute-on-chronic liver failure","volume":"235","author":"Inagaki","year":"2015","journal-title":"Tohoku J. Exp. Med."},{"key":"10.1016\/j.jaut.2018.10.004_bib223","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1055\/s-2005-916321","article-title":"Antinuclear antibodies in primary biliary cirrhosis","volume":"25","author":"Invernizzi","year":"2005","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.jaut.2018.10.004_bib224","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1159\/000444472","article-title":"Variant syndromes of autoimmune liver diseases: classification, diagnosis and management","volume":"34","author":"Weiler-Normann","year":"2016","journal-title":"Dig. Dis."},{"key":"10.1016\/j.jaut.2018.10.004_bib225","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/gutjnl-2016-311739","article-title":"Anti-GP2 IgA autoantibodies are associated with poor survival and cholangiocarcinoma in primary sclerosing cholangitis","volume":"66","author":"Jendrek","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.jaut.2018.10.004_bib226","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1365-2249.2010.04288.x","article-title":"Autoantibodies to GW bodies and other autoantigens in primary biliary cirrhosis","volume":"163","author":"Stinton","year":"2011","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jaut.2018.10.004_bib227","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/liv.12690","article-title":"Anti-kelch-like 12 and anti-hexokinase 1: novel autoantibodies in primary biliary cirrhosis","volume":"35","author":"Norman","year":"2015","journal-title":"Liver Int."},{"key":"10.1016\/j.jaut.2018.10.004_bib228","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0137927","article-title":"Two of Them Do It Better: novel Serum Biomarkers Improve Autoimmune Hepatitis Diagnosis","volume":"10","author":"Mazzara","year":"2015","journal-title":"PloS One"}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841118305183?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841118305183?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T21:16:42Z","timestamp":1775251002000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841118305183"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":227,"alternative-id":["S0896841118305183"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2018.10.004","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The clinical usage and definition of autoantibodies in immune-mediated liver disease: A comprehensive overview","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2018.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}